Hemoglobin level and macular thinning in sickle cell disease

S Amal Hussnain1 Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, CT, USA;2 Department of Ophthalmology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA;3 Vitreous Retina Macula Consultants of New York, New York, NY, USA;4 Department of Ophthalmology, New York University School of Medicine, New York, NY, USACorrespondence[email protected]

Patrick A Coady1 Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, CT, USA;5 New England Retina Associates, Hamden, CT, USA

Martin D Slade6 Department of Internal Medicine, Yale University School of Medicine and Yale School of Public Health, New Haven, CT, USA

Judith Carbonella7 Department of Pediatric Hematology and Oncology, Yale University School of Medicine, New Haven, CT, USA

Farzana Pashankar7 Department of Pediatric Hematology and Oncology, Yale University School of Medicine, New Haven, CT, USA

Ron A Adelman1 Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, CT, USA

Kathleen M Stoessel1 Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, CT, USA

show all

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Hemoglobin level and macular thinning in sickle cell disease

Articles from other publishers (3)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Hemoglobin level and macular thinning in sickle cell disease

Citations (3)

Articles from other publishers (3)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date